Issue 8, 2012

Aminoacyl tRNA synthetases as targets for antibiotic development

Abstract

Aminoacyl tRNA synthetases represent drug targets against which numerous small molecule natural products are available for further development into useful antibiotics. An understanding of the chemical properties, characterization of mode of action, and the elucidation of biosynthetic mechanisms for these molecules is necessary for the design of derivatives with enhanced pharmacological properties. Despite the ubiquity of small molecule natural products that inhibit tRNA synthetases, only a very small number of these compounds have been approved for clinical use. Here, we focus our discussion on tRNA synthetase inhibitor molecules of three different chemical classes, namely those derived from polyketide precursors, those that occur as phosphoramidate conjugates, and promising synthetic molecules with a mode of action that is distinct from molecules of the first two classes. Also discussed are the factors that undermine the broad-based use of some of these molecules as effective antibiotics in humans and strategies that may aid in directing the development of derivatives with improved pharmacological properties.

Graphical abstract: Aminoacyl tRNA synthetases as targets for antibiotic development

Article information

Article type
Review Article
Submitted
03 Feb 2012
Accepted
27 Feb 2012
First published
06 Mar 2012

Med. Chem. Commun., 2012,3, 887-898

Aminoacyl tRNA synthetases as targets for antibiotic development

V. Agarwal and S. K. Nair, Med. Chem. Commun., 2012, 3, 887 DOI: 10.1039/C2MD20032E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements